Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Traders Look to Upside - Comprehensive Research on 8x8 Inc., Lakeland Industries, Karyopharm Therapeutics and TETRA Technologies

EGHT, LAKE, TTI

NEW YORK, NY / ACCESSWIRE / December 11, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: 8x8 Inc. (NASDAQ: EGHT), Lakeland Industries Inc. (NASDAQ: LAKE), Karyopharm Therapeutics Inc. (NASDAQ: KPTI) and TETRA Technologies Inc. (NYSE: TTI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

EGHT Research Package: http://www.traders-choice.com/pdf?s=EGHT

LAKE Research Package: http://www.traders-choice.com/pdf?s=LAKE

KPTI Research Package: http://www.traders-choice.com/pdf?s=KPTI

TTI Research Package: http://www.traders-choice.com/pdf?s=TTI

============

Highlights from today's reports include:

On Thursday, December 10, 2015, Nasdaq Composite ended at 5,045.17, up 0.44%, Dow Jones Industrial Average advanced 0.47%, to finish the day at 17,574.75, and the S&P 500 closed at 2,052.23, up 0.23%.

- 8x8 Inc.'s stock edged lower by 2.35% to close Thursday's session at USD 10.82. The company's shares oscillated between USD 10.76 and USD 11.15. The stock recorded a trading volume of 0.45 million shares, which was below its 50-day daily average volume of 0.66 million shares and below its 52-week average volume of 0.65 million shares. Over the last three days, 8x8 Inc.'s shares have declined by 1.73% and in the past one week the stock has moved down 4.08%. Furthermore, over the last three months, the stock has gained 37.48% and in the past six months, the shares have picked up 20.09%. The stock is at a price to book ratio of 3.74 which compares to a historical PB ratio of 2.72. Additionally, the stock is trading at a price to cash flow ratio of 49.95 and at a price to sales ratio of 5.45.

- The stock of Lakeland Industries Inc. gained 2.10% to close Thursday's session at USD 14.86. The shares of the company moved in the range of USD 14.32 and USD 15.40. A trading volume of 0.33 million shares was recorded, which was greater than its 150-day daily average volume of 0.12 million shares and above its 52-week average volume of 0.15 million shares. Over the last five days, Lakeland Industries Inc.'s shares have advanced 5.24% and in the past one month, the stock has gained a momentum of 16.55%. Additionally, over the last three months, the stock has advanced 58.59% and in the past six months, the shares have registered a profit of 21.11%. Further, the company is trading at a price to earnings ratio of 7.89 and the stock is at a price to book (mrq) ratio of 1.55. This compares to a historical PE ratio of 6.40. The historical PB ratio is near to 0.95.

- Karyopharm Therapeutics Inc.'s stock increased by 1.00% to close Thursday's session at USD 15.15. The company's shares fluctuated in the range of USD 14.81 and USD 15.24. A total of 0.32 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.28 million shares but was below its 52-week average volume of 0.39 million shares. Over the last three days Karyopharm Therapeutics Inc.'s shares have advanced 0.60% and in the past one week the stock has moved down 7.51%. Furthermore, over the last three months, the stock has gained 4.20% while in the past six months, the shares have shed 46.10%. The stock is trading below its 50-day moving average of USD 15.71 and also below its 200-day moving average of USD 18.43. Additionally, the stock is at a price to book (mrq) ratio of 2.43 and at a price to sales (ttm) ratio of 2233.26.

- TETRA Technologies Inc.'s stock added 0.82% to close Thursday's session at USD 8.58. The company's shares oscillated between USD 8.44 and USD 8.77. The stock recorded a trading volume of 0.56 million shares, which was below its 50-day daily average volume of 0.75 million shares and below its 52-week average volume of 0.83 million shares. Over the last five days, TETRA Technologies Inc's shares have declined by 6.94% while in the past one month, the stock has gained a momentum of 9.44%. In addition, over the last three months, the stock has surged 19.00% and year to date, the shares have picked up 28.44%. The stock is at a price to book ratio of 1.80. The historical PB ratio is near to 1.44. Additionally, the stock is trading at a price to cash flow ratio of 3.37 and at a price to sales ratio of 0.58.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice